Genomic Health

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Genomic Health and buy or sell other stocks, ETFs, and their options commission-free!

About GHDX

Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. 

CEO
Kevin T. Conroy
CEOKevin T. Conroy
Employees
Employees
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
2000
Founded2000
Employees
Employees

GHDX Key Statistics

Market cap
2.38B
Market cap2.38B
Price-Earnings ratio
43.41
Price-Earnings ratio43.41
Dividend yield
Dividend yield
Average volume
1.81M
Average volume1.81M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$86.70
52 Week high$86.70
52 Week low
$50.77
52 Week low$50.77

Stock Snapshot

Genomic Health(GHDX) stock is priced at $63.44, giving the company a market capitalization of 2.38B. It carries a P/E multiple of 43.41.

On 2025-12-18, Genomic Health(GHDX) stock opened at —, reached a high of —, and a low of —.

The Genomic Health(GHDX)'s current trading volume is 0, compared to an average daily volume of 1.81M.

During the past year, Genomic Health(GHDX) stock moved between $50.77 at its lowest and $86.70 at its peak.

During the past year, Genomic Health(GHDX) stock moved between $50.77 at its lowest and $86.70 at its peak.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.